Dr. Michael E. Luggen, MD

Dr. Luggen practices at UC Medical Center in Cincinnati, Ohio.

Dr. Luggen's NPI, 1386635431, was assigned on October 28, 2005. Dr. Luggen graduated from Columbia University College of Physicians and Surgeons in 1974. Dr. Luggen holds Ohio license 35040536.

Dr. Luggen's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Luggen's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Luggen is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Luggen to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luggen practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Luggen's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Luggen is licensed in Ohio.

CMS data shows 2,230 Medicare services from Dr. Luggen across 11 procedure codes in 2024, for 185 Medicare patients. Medicare paid $68,343 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Luggen in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have arthritis, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Luggen's median patient age at 61, with 73% women.

In 2024, Dr. Luggen wrote 3,845 Medicare Part D claims for 363 patients. 86% of them were for generic drugs. CMS names the drug for 3,590 of them, across 53 drugs with 11 or more claims each, at $2,726,140 in total drug cost. In 2023, CMS named 3,828 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Luggen for performance year 2024, reported as part of a group. Dr. Luggen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Luggen as offering telehealth.

Dmand AI links 11 papers to Dr. Luggen, published from 2011 to 2024. 2011 was the busiest year, with 2. The most frequent topics are Antirheumatic Agents, Arthritis, Rheumatoid and Drug Therapy, Combination. Dr. Luggen has published most often in Ann Rheum Dis. Dr. Luggen's most frequent co-authors are Roy Mitchel Fleischmann, MD, Gaurav Gulati, MD and Marc A. Antonchak, MD.

Dmand AI links Dr. Luggen to 10 clinical trials, 5 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Lupus Erythematosus, Systemic. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Luggen that name 5 trials.

CMS Open Payments shows 22 general payments to Dr. Luggen from 4 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 80% of the total. Sun Pharmaceutical Industries Inc. paid the most, $9,030. It also lists 36 research payments totaling $8,685 from 2016 to 2022, naming 5 clinical trials.

Dr. Luggen graduated from Columbia University College of Physicians and Surgeons in 1974.